'Viagra' for women to hit the shelves soon

Good news for women who want to wake the act in their bedroom, the Food and Drug Administration group said, to approve the first pill to do for women what Viagra does for men, ornamental their sex lives.

A German pharmaceutical giant will sell a drug with the definitely unsexy name of "flibanserin" who have established skills to raise women's sex drive by messing with her brain chemicals.

FDA's Reproductive Health Drugs Advisory group meeting on 18 June to believe the request.

But the forecast of the drug endorsement has already sparked debate about whether the drugs those others in the tube is a long overdue step toward equity in women's health, or the latest case in point of the pharmaceutical industry fabricating a dubious distress selling needless and potentially unsafe substance.

"To attain a happy and healthy sex life can be a real and significant problem for some women. But we have many question about the" pink Viagra, "Washington Post quoted Amy Allin of the National Women's Health Network, a Washington-based advocacy collection to say.

Viagra is the catapult Blockbuster status in 1998 after the endorsement of setting a flurry of attention in me-too drugs for women.

But drug maker Pfizer hopes that the "little blue pill" will also catch fire female libido fizzled, make it clear that a woman's sexuality is more complex than a man.

But Germany's Boehringer Ingelheim am hopeful that flibanserin is about to become the first to print the instruction drugs what some have estimated could be a two billion U.S. dollars in the U.S. market alone.

"We believe women deserve the chance and we hope flibanserin may represent a safe and effective choice for many women," said Michael Sand, director of the company's clinical research flibanserin.

The researchers found that flibanserin, developed as an antidepressant, was ineffective in the action of despair.

But the drug prove to produce an unexpected side effect: promote women's libido.

This caused the corporation to investigate it for hypoactive sexual desire disorder, or HSDD, an otherwise unexplainable loss of sexual thoughts, dreams and desires that can cause important emotional suffering.

Some studies suggest 10 percent of women pain from HSDD.

"It's not that they are reluctant to sex. It's just that they do not worry about it. You just stop thinking about it. It's like a switch is twisted. There is a loss for them. They are absent it. Andthey want it back, "says Anita H. Clayton, lecturer of psychiatry and neurobehavioral science at the University of Virginia who has studied tablets for the company.